Bridging Discovery and Diagnosis: Where Immunology Meets Artificial Intelligence
The American Uveitis Society convened on May 2, 2026 for its Spring Meeting co-chaired by Thuy Doan, MD, PhD, and Lynn Hassman, MD, PhD, bringing together members from across the country to explore the intersection of immunology, clinical care, and emerging technologies. This year's program centered on the rapidly evolving role of artificial intelligence in uveitis research and practice, alongside continued advances in gene therapy and ocular inflammation. The meeting started with our plenary session speakers outlined below, followed by a free paper session.
"Mechanisms and Modulation of Gene Therapy Associated Uveitis (GTAU)"
Delivered by Kathryn Pepple, MD, PhD, Associate Professor of Ophthalmology, Division Director of Uveitis, and Director of Clinical Research at the University of Washington.
"Artificial Intelligence in Uveitis: Opportunities and Challenges"
Delivered by Jayashree Kalpathy-Cramer, PhD, Professor of Ophthalmology, Chief of the Division of Artificial Medical Intelligence in Ophthalmology, and Director of Health Informatics at CCTSI, University of Colorado.
Kathryn Pepple, MD, PhD delivers the Nussenblatt Memorial Lecture
Jayashree Kalpathy-Cramer, PhD delivers the Smith Memorial Lecture
Thuy Doan, MD, PhD AUS, Spring Meeting Co-Chair, delivers the introduction
Dr. Naveen Karthik, MD, AUS Spring Meeting resident travel grant winner
Congratulations to Dr. Naveen Karthik on receiving the resident travel grant, and thank you to all members who attended and contributed to a successful meeting.
Search our listing of AUS members who provide clinical care for patients with uveitis and other ocular inflammatory diseases. Search by name or by location.
